# Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center"

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/budgetary-health-care-institution-of-the-omsk-region-clinical-oncology-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 31 |
| Citations | 90,838 |
| City | Omsk |
| Country | RU |
| Description | Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center" is a research organisation in Omsk, RU. OpenAlex records 332 works and 90,838 citations for it. 161 researchers list it as their most recent affiliation. |
| Homepage | http://buzookod.ru/ |
| OpenAlex ID | https://openalex.org/I4210091202 |
| Researchers | 161 |
| ROR ID | https://ror.org/00ermfs73 |
| Type | healthcare |
| Works | 332 |

## University papers

- [Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-plus-platinum-etoposide-versus-platinum-etoposide-in-first-line/)
- [Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-with-or-without-tremelimumab-plus-platinum-etoposide-versus-platinum/)
- [Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer](https://scholariq.org/papers/effect-of-first-line-serplulimab-vs-placebo-added-to-chemotherapy-on-survival-in/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Human Health and Disease](https://scholariq.org/topics/human-health-and-disease/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Healthcare Systems and Public Health](https://scholariq.org/topics/healthcare-systems-and-public-health/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.